A recent study entitled Elevation of glutathione as a therapeutic strategy in Alzheimers disease concludes: Increasing glutathione remains a promising therapeutic strategy to slow or prevent MCI and Alzheimers disease. Considering that glutathione levels continue to decline as we age, and that both AD and MCI increase with age, supplementation with effective glutathione can play an important role in prevention, or slowing the progression of this disease
A few important details often get missed in those headlines
MASH is a more severe form of MASLD
Basic monitoring should include the parameters tracked in clinical trials: body weight, waist circumference, blood pressure, resting heart rate, and subjective GI symptom assessment
Oxidative stress and ROS generation Many ototoxic drugs, particularly aminoglycosides and platinum-based chemotherapeutics, induce oxidative stress by increasing ROS production